Written by: Ellie Pranckevicius, FNP-BC, Aesthetic Nurse Practitioner & Aesthetic Injector | Facial Restoration & Regenerative Injectable Specialist, Mirror Plastic Surgery
Key Takeaways
-
AOD9604 is a targeted peptide fragment of HGH that promotes lipolysis in stubborn fat areas like the abdomen without disrupting blood sugar or muscle mass.
-
Clinical trials show significant fat reduction within 12 weeks, and many patients notice visible changes within the first month under supervised protocols.
-
AOD9604 has a strong safety profile with minimal side effects; 2026 FDA Category 1 status allows compounding under medical supervision, while online sources still carry contamination and dosing risks.
-
Most patients achieve the best results with custom stacks such as GLP-3R or Sermorelin combinations, personalized dosing, and correct subcutaneous injection technique.
-
For safe, effective AOD9604 therapy with expert guidance from Ellie Pranckevicius, book a consultation at Mirror Plastic Surgery today.
Meet Your Nurse Practitioner: Ellie Pranckevicius
Ellie Pranckevicius, FNP-BC, leads peptide therapies at Mirror Plastic Surgery with a rare blend of aesthetic expertise and advanced clinical training. She earned her Master’s in Nursing from the University of South Florida and spent four years in the Neuroscience ICU at Tampa General Hospital, where she developed deep experience in complex physiology and metabolic health. Her background as a licensed esthetician adds insight into body composition, skin quality, and aesthetic goals.
Ellie’s peptide therapy approach centers on education and personalized protocols. She designs custom peptide stacks based on your lab results and goals, rather than relying on generic templates. Her concierge care model includes 24/7 text support, step-by-step injection training, and ongoing monitoring to keep your treatment safe and effective. Each plan reflects your unique physiology, lifestyle, and weight loss objectives.
How AOD9604 Targets Stubborn Fat for Weight Loss
AOD9604 acts as a precision tool for fat metabolism, binding to beta-3 adrenergic receptors in adipose tissue to stimulate lipolysis, the breakdown of stored fat into free fatty acids. This action activates lipoprotein lipase, the enzyme that drives fat oxidation, while also reducing lipogenesis, or new fat formation. Unlike full HGH, AOD9604 does not affect blood sugar levels, insulin sensitivity, or IGF-1 production, which avoids the metabolic disruptions seen with traditional growth hormone therapy.
The peptide’s targeted action works like a focused beam melting fat cells in stubborn areas such as the abdomen, thighs, and arms where diet and exercise often fall short. AOD9604 preserves lean muscle mass while it targets adipose tissue, which makes it well suited for patients who want body recomposition rather than simple scale weight loss. Many patients see improved waistlines and clothing fit even when the number on the scale changes slowly.
Beyond this targeted fat breakdown, AOD9604 also supports the body’s underlying metabolic flexibility. The peptide helps your system shift more efficiently between glucose and fat as fuel sources. This improved fuel use often supports steadier energy, fewer cravings, and better adherence to long-term weight management plans.
Does AOD9604 Work for Weight Loss? Real Results and Timelines
Clinical evidence strongly supports AOD9604’s effectiveness for targeted fat loss. Phase II trials demonstrated weight loss over 12 weeks, with participants experiencing meaningful reductions in abdominal fat. Mirror Plastic Surgery patients often notice early changes within the first week when they follow supervised peptide protocols for weight management.
The timeline below shows what you can expect at each stage, comparing clinical trial milestones with the types of outcomes Ellie typically sees in Mirror patients under supervision:
|
Timeline |
Expected Results |
Mirror Cases |
|---|---|---|
|
Weeks 1-4 |
Initial water and fat loss |
Early body composition changes |
|
Months 1-3 |
Ongoing total body fat reduction |
Noticeable weight loss and inches lost |
|
12+ weeks |
Sustained results with maintenance |
Long-term body composition improvement |
Patient testimonials often describe visible changes in stubborn belly fat within the first month of treatment. One Mirror patient shared, “I lost 15 pounds in the first month following Ellie’s protocol, with most of the loss coming from my midsection where I’d struggled for years.” AOD9604’s ability to target both visceral and subcutaneous fat that usually resists conventional methods explains these types of results.
Outcomes vary based on baseline body composition, consistency with the protocol, and lifestyle habits. Patients who pair peptide therapy with appropriate nutrition, movement, and sleep typically see faster and more pronounced changes.
AOD9604 Dosage for Fat Loss and How to Take It
Effective AOD9604 dosing relies on careful titration based on your response and tolerance. Clinical protocols use subcutaneous doses that your provider adjusts to your specific needs and medical history.
|
Experience Level |
Dosage |
Frequency |
Cycle Length |
|---|---|---|---|
|
Beginner |
Customized by provider |
Once daily |
Customized cycles |
|
Intermediate |
Customized by provider |
Once daily |
Customized cycles |
|
Advanced |
Customized by provider |
Once or twice daily |
Customized cycles |
Patients administer AOD9604 as a subcutaneous injection into the abdominal area, at least 2 inches from the navel, using a 29 to 31 gauge insulin syringe. Rotating injection sites helps prevent tissue buildup and supports consistent absorption. AOD9604 reaches peak plasma concentrations within 30 to 60 minutes of injection, and metabolic effects can persist for 12 to 24 hours. Understanding this timing helps Ellie plan dosing schedules that fit your daily routine and goals.
Ellie provides detailed injection training, reconstitution videos, and ongoing support so you feel confident with each dose. Schedule with Ellie for personalized peptide dosing and administration guidance.
AOD9604 Side Effects, Safety, and Unsupervised Use Risks
AOD9604 has shown an excellent safety profile in clinical trials, with adverse events in fewer than 5% of participants. Reported issues usually remain mild, such as temporary injection site irritation or short-lived headaches. Six randomized, double-blind, placebo-controlled trials involving over 900 participants found AOD9604’s safety profile indistinguishable from placebo, with no serious adverse events linked directly to the peptide.
The 2026 FDA reclassification moved AOD9604 from Category 2 to Category 1 status, which allows licensed compounding pharmacies to prepare it under physician supervision. This change supports safer access through medical practices. It does not, however, regulate the gray market, where contaminated, mislabeled, or inactive products still pose serious risks.
Unsupervised AOD9604 use exposes patients to three major problems. First, contaminated or misformulated products from unregulated sources can trigger infections or allergic reactions. Second, incorrect dosing without medical guidance often leads to poor results and wasted money. Third, the absence of ongoing monitoring means side effects or lack of progress may go unnoticed and unaddressed.
Mirror Plastic Surgery’s supervised model addresses each of these issues through vetted sourcing, strict quality controls, and Ellie’s 24/7 clinical support throughout treatment.
Best Peptide Stacks for Fat Loss at Mirror Plastic Surgery
Thoughtful peptide combinations can amplify fat-targeting effects while addressing appetite, muscle preservation, and metabolic health. The table below highlights two of Mirror’s most effective stacks and shows how each combination supports different aspects of weight loss and body composition:
|
Stack Combination |
Primary Benefits |
Expected Results |
|---|---|---|
|
GLP-3R |
Reduced GI side effects, muscle preservation |
Significant weight loss |
|
Sermorelin/Ipamorelin |
Natural GH support with targeted fat loss |
Improved body composition |
GLP-3R represents a newer generation GLP-1 agonist that tends to cause fewer gastrointestinal side effects and less muscle loss than older agents. Clinical trials show enhanced efficacy when targeted agents are combined with appetite-regulating peptides, especially for patients with higher starting weights.
Ellie builds each stack around your lab results, weight loss goals, and tolerance profile. She considers insulin sensitivity, thyroid function, prior medication responses, and lifestyle factors to create combinations that match your physiology rather than forcing a standard protocol.
Why Patients Choose Mirror Plastic Surgery for Peptide Therapy
Mirror Plastic Surgery’s concierge model offers a structured, medically supervised path for peptide-based weight management. Each patient begins with a 30 to 60 minute consultation that includes detailed lab analysis of thyroid function, metabolic markers, and hormone panels. This evaluation confirms that peptide therapy fits your health status and aligns with your body composition goals.
Unlike high-volume clinics or anonymous online vendors, Mirror provides tailored protocols with consistent follow-up. Ellie’s 24/7 text access allows quick answers to questions and rapid adjustments when needed. Our rigorous sourcing and quality checks protect you from the uncertainty of gray-market products. When appropriate, we pair peptide therapy with Dr. Akash Chandawarkar’s surgical expertise to complete a comprehensive body contouring plan.
Our St. Petersburg office serves the Tampa Bay area with in-person visits, and our telemedicine platform extends supervised peptide care across the country. This access allows you to work with Ellie from your home while still receiving structured medical oversight.
Book an appointment with Ellie to start your supervised peptide protocol today.
Frequently Asked Questions
Does AOD9604 work without diet and exercise?
AOD9604 and related peptides can produce fat loss on their own, although results improve significantly with supportive nutrition and movement. Ellie helps each patient adjust lifestyle habits so the peptide’s effects translate into steady, visible progress and long-term maintenance.
How does AOD9604 compare to Semaglutide for weight loss?
AOD9604 and Semaglutide act through different pathways, which makes them complementary tools. Semaglutide reduces appetite and slows gastric emptying, leading to lower caloric intake. AOD9604 directly targets fat cells for breakdown, regardless of hunger levels. Many patients see stronger and more sustainable results when these approaches are combined under medical supervision at practices like Mirror Plastic Surgery.
Is AOD9604 FDA-approved and safe to use?
AOD9604 is not FDA-approved as a pharmaceutical drug, and many peptides fall outside traditional FDA regulation. Supervised medical use through qualified providers such as Mirror Plastic Surgery includes screening, individualized dosing, and monitoring, which supports safety and consistent outcomes. Clinical trials to date have shown an excellent safety profile without serious peptide-related adverse events.
What are the risks of buying AOD9604 online?
Online AOD9604 sources carry high risks, including contamination, incorrect or missing active ingredients, improper storage, and no medical oversight. Independent testing of gray-market peptides has revealed frequent mislabeling, bacterial contamination, and products with no active peptide at all. Mirror’s quality controls, described earlier, ensure you receive authentic, properly dosed peptides with full medical supervision throughout treatment.
How quickly will I see results and how long do they last?
As noted earlier, most patients begin noticing early body composition changes within the first month, with more significant fat loss often appearing by weeks 6 to 8. Results usually continue to build over a 12 to 16 week cycle. Maintenance may involve low-dose ongoing therapy or periodic cycles, because the peptide’s effects gradually fade after discontinuation. When progress slows, Ellie can adjust your protocol to help you move past plateaus and maintain your results.
Peptide therapy offers a targeted, medically guided option for fat loss when used under proper supervision. Mirror Plastic Surgery’s comprehensive protocols with Ellie Pranckevicius provide a safe, structured path that addresses your specific weight loss challenges. Book an appointment with Ellie to explore how peptides can support your body composition goals.
Contact Information:
Phone: 727-361-6515
Email: hello@mirrorplasticsurgery.com
Address: 780 4th Ave S, St. Petersburg, FL 33701
Instagram: @mirrorplasticsurgery, @dr.akashplasticsurgery
Disclaimer: Results may vary from person to person. Editorial content, before and after images, and patient testimonials do not constitute a guarantee of specific results.
Disclaimer: Peptide therapy is intended for wellness and optimization purposes and is not prescribed to diagnose, treat, cure, or prevent disease unless specifically stated. Many peptides are not FDA-approved and may be used off-label. Some have limited long-term safety data, with a potential for unknown risks, complications, or desensitization with prolonged use.
